The purpose of the present study was to identify the clonal characteristics and gyrA gene diversity of ciprofloxacin-resistant meningococcal strains in China. One hundred and forty-one ciprofloxacin-resistant and 103 ciprofloxacin-susceptible meningococcal strains were selected for multilocus sequence typing. Of these, 54 ciprofloxacin-resistant and 42 ciprofloxacinsusceptible strains were selected for gyrA gene sequencing. Of the three clonal complexes prevalent in China, serogroup A of ST-5 complex (CC5) and serogroup C/B strains of CC4821 had a high proportion of ciprofloxacin resistance, whereas CC11 serogroup W strains were all susceptible. Nucleotide and amino acid sequences of the gyrA gene among ciprofloxacinresistant strains showed more diversity than those among ciprofloxacin-susceptible strains. All ciprofloxacin-resistant strains had a T91I mutation and the ciprofloxacin-susceptible strains had no T91I mutation. Phylogenetic analysis showed that the gyrA gene sequences of CC4821 serogroup B/C strains, CC11 serogroup W, CC1 serogroup A, ciprofloxacin-susceptible CC5 serogroup A and reference strains had high similarity. By contrast, the ciprofloxacin-resistant CC5 serogroup A strains had a highly conserved gyrA gene sequence which was different (94.8 % similarity) from that in the above strains. The results of our investigation showed that the high proportion of ciprofloxacin resistance in Neisseria meningitidis is associated with certain sequence types (STs) or clonal complexes (CCs). The prevalence of certain CCs with a high proportion of ciprofloxacin resistance can facilitate the spread of ciprofloxacin resistance.
INTRODUCTION
Neisseria meningitidis is one of the main pathogens causing sporadic or outbreak cases of bacterial meningitis worldwide (Jafri et al., 2013) . As a vaccine-preventable disease, meningococcal meningitis has changed dramatically in terms of incidence and prevalent serogroups, with the expanding application of vaccines against specific N. meningitidis serogroups (Bona & Guidi, 2012; Jafri et al., 2013; Zhou et al., 2012) . In China, since a polysaccharide vaccine against serogroup A was included in the routine immunization program in 1984, the incidence of meningococcal meningitis has decreased to less than 0.2 %. However, studies have also demonstrated the important role of antibiotics in the control and prevention of meningococcal disease, similar to that in many other bacterial infections (Connolly & Golden, 2011; Manchanda et al., 2006) . When infection occurs, appropriate antibiotic therapy is undoubtedly the most efficient strategy for saving lives (Terranella et al., 2012) , and urgent chemoprophylaxis is an effective intervention for the close contacts of case patients (Gardner, 2006) .
In recent years, ciprofloxacin has commonly been recommended as chemoprophylaxis to prevent the spread of meningitis outbreaks (Zalmanovici Trestioreanu et al., 2011) . Although researchers from several countries have reported ciprofloxacin resistance of N. meningitidis, the proportion of resistance remains low (Enríquez et al., 2008; Gorla et al., 2011; Lapadula et al., 2009; Shultz et al., 2000; Singhal et al., 2007; Strahilevitz et al., 2008; Wu et al., 2009) . In China, ciprofloxacin has been recommended as chemoprophylaxis since 2005 when the resistance of N. meningitides to sulfanilamide became severe. However, ciprofloxacin-resistant strains have been increasingly isolated throughout China recently and the proportion of resistant strains is now obviously higher than in other countries. As a consequence, other antibiotics, such as azithromycin, have been used in some meningitis outbreaks. Of the reported ciprofloxacin-resistant strains from other countries, most belonged to serogroups A and B while the others belonged to serogroups Y, W and C and a non-groupable type. By contrast, the resistant strains in China belonged to different serogroups and there were significantly more resistant isolates in serogroup A than that in the other serogroups (data not published).
As previously described in other studies (Jafri et al., 2013; Shao et al., 2006; Zhou et al., 2012) , N. meningitidis isolates circulating in China differ from those in other countries not only in terms of their prevalent serogroups but also in sequence types (STs) or clonal complexes (CCs). Since the late 1990s, the main N. meningitidis serogroups isolated in the eastern Mediterranean, American and European regions were B, C or Y. N. meningitidis serogroup A is mainly endemic to Africa (CC5) (Hedberg et al., 2009 ) and the western Pacific region. In China, serogroup A accounted for 95 % of the cases of meningococcal disease between 1956 and 2005 (Zhang et al., 2008) . CC5 and CC1 were responsible for most of these cases. Since two outbreaks of a new serogroup C meningococcal disease emerged during [2003] [2004] , N. meningitidis serogroup C isolates belonging to CC4821 have been the second dominant lineage in China. To complicate this, serogroup B isolates of CC4821 were found circulating in healthy carriers and patients, indicating a capsular switch that probably occurs between the strains of serogroups C and B. Moreover, from 2005 to 2010, N. meningitidis infections from CC11 serogroup W have markedly increased in China (Zhou et al., 2013) . Although N. meningitidis strains of CC1, CC5 and CC11 had also been epidemic in other regions around the world, the combination and alternative patterns of the associated clone complex/lineages prevalent in China have not been observed in other countries. According to previous studies, the major mechanism of the emerging ciprofloxacin resistance for N. meningitidis strains is a nucleotide mutation leading to a threonine-to-isoleucine substitution at amino acid 91 (T91I) in the gyrA gene (Alcalá et al., 2004; Enríquez et al., 2008; Hong et al., 2013; Singhal et al., 2007) . The mutation in the mtrRCDE gene complex was also reported to be related to ciprofloxacin resistance (Chu et al., 2007; Corso et al., 2005; Enríquez et al., 2008) . The resistance was occasionally produced by the recombination of the ciprofloxacin-resistant gyrA between Neisseria lactamica and N. meningitidis (Wu et al., 2009) .
In this study, we hypothesized that a high proportion of ciprofloxacin resistance in N. meningitidis is associated with certain serogroups or STs. The gyrA gene sequences, which are different from those identified previously, may exist in some N. meningitidis isolates from China. We performed this study to characterize the clonal characteristics and gyrA gene diversity of ciprofloxacin-resistant meningococcal strains in China.
METHODS
Meningococcal strains and DNA preparation. Since the 1960s, more than 2000 N. meningitidis isolates have been collected in our laboratory from patients and asymptomatic carriers throughout China. The serogroups of all the strains were determined by slide agglutination with specific rabbit antisera (BD Difco). From this collection of isolates, we selected 487 representative strains based on the isolation region (29 provinces), serogroup, isolation year and source (patient or healthy carrier) for antibiotic susceptibility testing (12 antibiotics). The antibiotic susceptibility testing was performed according to the Clinical and Laboratory Standards Institute (CLSI, 2010) guidelines. Among these tested strains, 353 (72.5 %) showed decreased susceptibility to ciprofloxacin. Of these, 141 ciprofloxacinresistant (MIC¢0.12 mg ml
21
) and 103 ciprofloxacin-susceptible (MIC¡0.03 mg ml 21 ) meningococcal strains were selected for analysis in this study. These strains were isolated from sterile sites of patients (n5127) or pharynges of healthy carriers (n5117). Among these 244 strains, 207 were isolated between 2005 and 2012, and the other 37 were isolated between 1963 and 2004. They belonged to the A (n568), B (n541), C (n590), X (n52), Y (n51), W (n513), E (n52) and non-serogroupable (n527) serogroups. The 27 nonserogroupable strains were genogrouped using primers specific for serogroups A, B, C, W, Y, E, X, Z and capsule null locus (cnl) (DolanLivengood et al., 2003; Taha, 2000) . Of these, 25 were identified as C (n57), B (n54), W (n54), E (n51), X (n51) and cnl (n58). The other two could not be amplified in all the PCRs and were termed non-genogroupable. The serogroup/genogroups of the 141 ciprofloxacin-resistant strains were A (n538), B (n528), C (n564), Y (n51), W (n53), E (n53), X (n51) and cnl (n53).
The selected isolates were propagated on single plates of Columbia agar (Difco TM Columbia Blood Agar Base with 5% Sheep Blood) in a 5 % CO 2 atmosphere at 37 uC for 18 h. Genomic DNA was extracted using a DNA mini-kit (Qiagen) according to the manufacturer's instructions.
Multilocus sequence typing (MLST). MLST was performed as described by Maiden et al. (1998b) . The corresponding STs and CCs were assigned by querying the database available at http://pubmlst.org/.
Sequencing of the gyrA gene. The gyrA gene was amplified from freshly prepared DNA. PCR was performed using the following primer pair: gyrA-F, 59-GTTCCGCGTCAAAATATGCT-39 (Strahilevitz et al., 2008) and gyrA-2844R, 59-GACTATAATCCGCTATATTGT-39 (this study). The PCR thermal cycle started with a denaturation step of 95 uC for 5 min; followed by 30 cycles of 94 uC for 1 min, 55 uC for 1 min and 72 uC for 2 min; with a final extension step of 72 uC for 5 min. The PCR fragments were sequenced using three more primers in addition to the ones used for amplification: gyrA-1118R: 59-CGGG-TAACGACTTCGCGGTG-39 (this study), gyrA-1619R: 59-CAATGTC-GCCGCCGAACGGGTTG-39 (Wu et al., 2009 ) and gyrA-1383F: 59-GAGCGAGATTCAGGCAGATGC-39 (Wu et al., 2009) . The sequence of each locus was analysed on an ABI Prism 3130 or 3730 DNA sequencer (Applied Biosystems). Complete gene sequences (nucleotides 1-2751) were acquired from study strains.
Analysis of sequence data. Sequence data of the gyrA gene were analysed using Lasergene 7 (DNASTAR). Phylogenetic analysis was performed using MEGA software (version 4.0). Single nucleotide polymorphisms (SNPs) were detected and analysed using MUSCLE software (version 3.6) and PERL scripts. Eight gyrA reference sequences (N. meningitidis: 8013, FAM18, Z2491, WUE2594, 053442 and MC58; N. lactamica: NL020-06; and Neisseria gonorrhoeae: NG1090) were downloaded from GenBank for comparison in the data analysis. One previously reported ciprofloxacin-resistant N. meningitidis strain (M16207) and its potential donor strain (N. lactamica strain NLM17102) were also employed in the comparison analysis (Wu et al., 2009) .
RESULTS

STs of study strains
A total of 214 study strains were identified to belong to 17 CCs and 50 STs. The remaining 30 strains belonged to 25 STs which remained unassigned to a CC (UA). The ciprofloxacin-resistant strains belonged to different CCs and STs. Of the 44 ST-7 serogroup A strains, 36 were found to be resistant to ciprofloxacin, and there was no ciprofloxacin-resistant strain in the other two dominant STs of serogroup A, namely, ST-3 (n57) and . CC4821 was the other main ciprofloxacin-resistant clonal complex. More than half of the CC4821 strains (n563) exhibited resistance to ciprofloxacin, irrespective of genogroups. The ST-11 serogroup W isolates (n511), whose incidence in China has been markedly increasing in recent years, were all susceptible to ciprofloxacin. The STs and CCs of the 244 study strains are shown in Table 1 .
Nucleotide diversity of the gyrA gene Ninety-six of the 244 study strains were selected according to their serogroups/genogroups and STs for gyrA gene sequencing. The gyrA sequences of six reference N. meningitidis strains shared over 99 % similarity. The gyrA sequences of 56 study strains also showed a high level of similarity (¢99.3 %) to the reference strains, and were designated variant group I. These included serogroup B and C strains of CC4821, serogroup W of CC11, serogroup A of CC1, ciprofloxacin-susceptible serogroup A of CC5, and some strains belonging to unusual STs.
Most (24/25) ciprofloxacin-resistant serogroup A and C strains of CC5 (ST-7, 22; ST-5082 and ST-5084, one for each) had the same gyrA gene sequences (variant group II). However, they shared lower similarity (94.8 %) with the sequences of the reference strain WUE2594 and ciprofloxacin-susceptible serogroup A, which also belongs to CC5. The remaining one ciprofloxacin-resistant serogroup A strain of CC5 (strain 30) had the same gyrA sequence as those in variant group II at the last 1304 nt, although the first 1447 nt shared only 96.2 % and 97.3 % similarity to the corresponding regions of variant group II and WUE2594 gyrA, respectively.
The gyrA sequences of 15 other strains (other variants) showed 93-99 % and 88.5-96.7 % similarity to those in variant group I and variant group II, respectively. They also shared low similarity (87.8-97.8 %) with each other except that strain D1 had an identical gyrA sequence to strain D3. These strains belonged to serogroup/genogroups B, E, W, Y and non-groupable and were of different clonal complexes. Except for one strain, all strains exhibited ciprofloxacin resistance. The similarity between the gyrA sequences of strain C4 and N. lactamica NLM17102 was 96.8 %, which was higher than that between the gyrA sequences of C4 and other N. meningitidis strains. A phylogenetic analysis of the gyrA sequences from 96 study strains and 10 reference strains is shown in Fig. 1 . The SNPs of the gyrA gene from these 15 other variant strains as well as strain 30, two reference strains, and one variant group II strain were compared. The results showed that the identity between two strains was uneven along the gene, with as high as 100 % identity at some regions and as low as 95.2 % at others (strains 63 and 64; Fig. 2 ).
Amino acid diversity of gyrA
We identified 31 types of amino acid sequences of the gyrA gene in the 96 study strains. Of these, 10 and 21 sequences were found in ciprofloxacin-susceptible and ciprofloxacinresistant strains, respectively. Strain C4 had the most amino acid alterations (32 substitutions) as compared with variant group I strains, and the alterations were dispersed through the sequence. Ciprofloxacin-resistant strains showed more amino acid alterations than ciprofloxacin-susceptible strains. All the ciprofloxacin-resistant strains had a T91I mutation, and none of the ciprofloxacin-susceptible strains had T91I mutations. Apart from the T91I mutation, all ciprofloxacin-resistant strains had an isoleucine-to-valine substitution at amino acid 249 (I249V). However, this substitution was also present in 9 of the 10 amino acid sequences in ciprofloxacin-susceptible strains. All the amino acid substitutions of the gyrA gene from 95 study strains are shown in Fig. 3 (strain C4 was excluded because it had remarkably more alterations than the other strains).
DISCUSSION
From the results of the phylogenetic analysis of DNA sequences and amino acid sequence alterations, the gyrA sequences of ciprofloxacin-resistant CC5 serogroup A strains were found to be distinct from those of ciprofloxacin-susceptible CC5 serogroup A and other ciprofloxacin-resistant meningococcal strains. The low similarity between these sequences indicates that the gyrA gene of ciprofloxacin-resistant CC5 serogroup A is a product of recombination. We searched this gyrA sequence using BLAST on NCBI, and found ,95 % similarities with the reference sequences, and the maximum similarities were found with the corresponding sequences of N. meningitidis or other Neisseria species. Analysis of the SNPs showed that all the SNPs on variant group II sequences could be found on the gyrA sequences from other variants. Thus, we suppose that the gyrA in variant group II was introduced by horizontal gene transfer from an unknown N. meningitidis strain or from other related Neisseria species. In fact, similar recombinations among different Neisseria species have been described previously (Maiden, 1998a; Wu et al., 2009) . However, it would be important to identify the donor in order to confirm this event and related gene transfer mechanism.
The ciprofloxacin-resistant CC5 strains identified in this study were isolated from 15 provinces since 2005; their gyrA sequences were identical to each other, which corresponded to a clonal epidemic expansion of these isolates. The ciprofloxacin resistance in CC5 serogroup A strains has also been reported in other countries, although the isolates belonged to the ST-4789 sequence type and not ST-7 as in China (Lapadula et al., 2009; Singhal et al., 2007; Strahilevitz et al., 2008) . In these studies, only short quinolone resistance-determining regions (QRDRs) of the gyrA gene were sequenced; therefore, no sequences were available from previous studies for comparison with the complete gyrA gene sequences in the present study. However, the amino acid substitutions in the QRDRs of CC5 serogroup A strains from different countries were identical. Because some ST-7 serogroup A strains were ciprofloxacin-susceptible and shared similar gyrA sequences with reference strains, we suppose that a new gyrA allele was initially transferred into an ST-7 strain. Strains belonging to other STs were derived from this ST-7 strain because it is almost impossible for two separate strains to acquire the same gene by recombination. If this is true, ciprofloxacinresistance in serogroup A strains was produced mainly by this new gyrA allele. Countries should take concern and caution regarding the spread of this strain whether or not they have encountered cases of serogroup A meningitis previously. However, to confirm our findings, the full gyrA sequences of ciprofloxacin-resistant ST-4789 serogroup A strains must be sequenced in further studies.
Although N. meningitidis strains might acquire ciprofloxacin resistance by different mechanisms, such as point mutation and horizontal gene transfer, a T91I mutation existed exclusively in ciprofloxacin-resistant strains. Another suspected resistance-related mutation (D95N) that has been reported previously (Corso et al., 2005; Hong et al., 2013; Shultz et al., 2000) was not observed in our study strains. In addition, these two groups of strains (with and without D95N) were indistinguishable by their MIC values. These results indicate that the T91I amino acid alteration is enough for resistance conversion. Nevertheless, more research is required to identify the effect of other mutations on the function of gyrA.
Capsular switching between ST-7 serogroup A and C strains has been described in a previous study (Wang et al., 2010) . In the present study, the ciprofloxacin-resistant ST-7 serogroup A and C strains had identical gyrA sequences, confirming that the ST-7 serogroup C strains were derived from ST-7 serogroup A by recombination of capsular genes. Also, our finding indicates that antibiotic resistance can be transmitted among serogroups by capsular switching.
Surveillance of the antibiotic susceptibility of N. meningitidis has typically focused on the clinical isolates (Hossain et al., 2009; Singhal et al., 2007; Vázquez et al., 2007b) . In the present study, however, 73 ciprofloxacin-resistant strains were obtained from healthy carriers, and some of the isolates possessed identical gyrA sequences to those obtained from patients, indicating that the carriers could serve as an effective mode of transmission of antibiotic resistance. In addition, the gyrA sequences of N. meningitidis isolates from carriers showed high diversity, suggesting that these strains could be part of a wide gene pool in which the recombination events occur. Considering the potential effect of the carrier strains in antibiotic resistance, isolates from both patients and carriers should be used to monitor antibiotic susceptibility.
When a meningococcal meningitis outbreak occurs, empiric antibiotic treatment and prevention are crucial because failure in antibiotic use increases the incidence of fatality and causes rapid spread of infection (Shehab et al., 1998) . However, the most effective antibiotics to be used for a certain infection are seldom known until antibioticsusceptibility testing has been carried out. Antibiotics can only be applied empirically on the basis of previous data. Thus, adequate data on the antibiotic susceptibility of meningococci are extremely important for the accurate use of antibiotic therapy for meningitis. Antimicrobial resistance surveillance has been performed in many countries to monitor the changes in antibiotic susceptibility of N. meningitidis (Enríquez et al., 2008; Skoczyń ska et al., 2013; Vázquez, 2007a; Wu et al., 2009 identify antibiotic resistance and to understand the mechanism by which resistance is developed and the modes of transmission of resistance. However, such studies are usually limited to one country or region and lack data from other regions, thus providing only a partial understanding of antibiotic resistance trends, because antibiotic resistance can disseminate globally. Therefore, an international surveillance system for antimicrobial resistance of N. meningitidis should be established and maintained. By this system, the recommended empirical antibiotics can be more accurate and resistance to specific antibiotics can be addressed more rapidly.
In conclusion, our study indicates that the high proportion of ciprofloxacin resistance in N. meningitidis is associated with certain STs. The prevalence of certain CCs which have a high proportion of ciprofloxacin resistance can facilitate the spread of ciprofloxacin resistance. 
